ORF_ID	CONTIG	START	STOP	ORIENTATION	CUT_OFF	PASS_EVALUE	Best_Hit_evalue	Best_Hit_ARO	Best_Identities	ARO	ARO_name	Model_type	SNP	Best_Hit_ARO_category	ARO_category	PASS_bitscore	Best_Hit_bitscore	bit_score	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	LABEL	ID	Model_id
BGC0000656.1|Zeaxanthin_2	ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.675	1323	2837	+	Loose	n/a	0.141448	tetX	31.48	ARO:3000205, ARO:3003461, ARO:3003295, ARO:3002513, ARO:3002542	Mycobacterium tuberculosis ndh mutant conferring resistance to isoniazid, tetX, AAC(3)-VIIIa, LRA-19, Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones	protein variant model, protein homolog model	n/a, V18A, D94A, n/a, n/a	antibiotic inactivation enzyme; determinant of tetracycline resistance	antibiotic inactivation enzyme; antibiotic resistant gene variant or mutant; determinant of aminoglycoside resistance; determinant of beta-lactam resistance; determinant of fluoroquinolone resistance; determinant of isoniazid resistance; determinant of tetracycline resistance	300	30.4166	30.4166, 27.7202, 25.0238, 25.0238, 24.6386	ATGATGCTCGATGCCACCAAGACCATCCGCCGCGCCGCCGTCATCGGGTCCGGCTTCGGCGGGCTCTCCCTCGCCATCCGCCTGCAGGCGGCGGGCATCCGCACCACCGTGTTCGAGCAGCGGGACAAGCCCGGCGGCCGCGCCTACGTCTATGAGCAGGACGGCTTCACCTTCGATGGCGGCCCCACCGTCATCACCGATCCCACCTGCCTGGAAGAAGTGTTCGCCGCCGCCGGCCGCAAGCTGTCCGACTATGTGGAGCTGATGCCGGTCTCGCCGTTCTACCGGCTGCTGTGGCCGGACGGCCGGCAGTTCGACTATGTGAACGACCAGGCCGCGCTGGACGCCCAGATCGCCACCTTCGATAAGGCGGACGTGGAGGGCTATCGCCGCTTCCTCGCCTATTCGCAGGCGGTCTTCGAGGAGGGTTATCTCAAGCTCGGCGCGGTGCCGTTCCTCGAATTCTCCAGCATGATGAAGGCCGCGCCCAAGCTGGTGAGGCTGGAAGCCTGGCGCTCGGTCTATGCCATGGTCTCGCGCTTCATCCGCGACGATCACCTGCGGCAGGCCTTCTCGTTCCATTCCCTGCTGGTGGGGGGCAATCCCTTCTCCACCTCGTCCATCTATGCCCTCATCCATGCGCTGGAGCGCAAGTGGGGCGTGTTCTTCCCCCGCGGGGGAACCGGCGCCTTGGTGCGCGGCATGGTCAAGCTGTTCACCGACCTCGGCGGCGAGATCCGCCTCACCAGCCCGGTGGACGAGATCGTGGTGGAGGGCCAGCGCGCCACCGCCGTGAAGCTCAAGAGCGGCGAGACCCTGCCGTTCGACCTCGTCGCCTCCAATGCGGACGTGGTGCACACCTATCGCCACCTTCTGCGCGGGGCGGCGCGCGGTCGCTCGGAAGGCGCGCGGCTGGCCAAGACGCGCCACTCCATGTCGCTGTTCGTCACCTATTTCGGGGCGCGGCGCACCTGGGACCATCTCCAGCACCACACGGTGCTGTTCGGTCCGCGCTATCGGGGCCTCGTGGACGAGATCTTCAAGGGCCCGAACCTTCCCGACGACTTCTCGCTCTATCTCCACGCGCCCACCGTGACAGACAAATCGCTGGCGCCGGAAGGCTGTACCGCCTTCTACGTGCTCTCGCCGGTGCCGCATCTGGGCAAGGCGGACATCGACTGGGAGGTGGAAGGCCCGCTCTATCGCGACCGCATCCTCGCCCATCTGGAAGAGCGGCTACTGCCGGGGCTGCGCGACAGCCTCGTCACCTCGCGCATCCTCACCCCCTTCGGCTTCCGCGACGAACTGTCCGCCCATCAGGGCTCGGCCTTCTCGGTAGAACCGCTCCTCACCCAGTCAGCGTGGTTCCGGCCGCACAACCGCGATGCCAAGATTGCCAACCTCTATTTCGCCGGGGCCGGCACCCATCCGGGGGCGGGCGTGCCGGGGGTGGTGGGCTCGGCCAAGGCCACGGCGGGGCTCATCCTCGCGGATCTGGGCGTGACGCCGCGATGA	MMLDATKTIRRAAVIGSGFGGLSLAIRLQAAGIRTTVFEQRDKPGGRAYVYEQDGFTFDGGPTVITDPTCLEEVFAAAGRKLSDYVELMPVSPFYRLLWPDGRQFDYVNDQAALDAQIATFDKADVEGYRRFLAYSQAVFEEGYLKLGAVPFLEFSSMMKAAPKLVRLEAWRSVYAMVSRFIRDDHLRQAFSFHSLLVGGNPFSTSSIYALIHALERKWGVFFPRGGTGALVRGMVKLFTDLGGEIRLTSPVDEIVVEGQRATAVKLKSGETLPFDLVASNADVVHTYRHLLRGAARGRSEGARLAKTRHSMSLFVTYFGARRTWDHLQHHTVLFGPRYRGLVDEIFKGPNLPDDFSLYLHAPTVTDKSLAPEGCTAFYVLSPVPHLGKADIDWEVEGPLYRDRILAHLEERLLPGLRDSLVTSRILTPFGFRDELSAHQGSAFSVEPLLTQSAWFRPHNRDAKIANLYFAGAGTHPGAGVPGVVGSAKATAGLILADLGVTPR	MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADKKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFMYGKEAQEESTQNEIEMFKPDFTFQQLLNV	BGC0000656.1|Zeaxanthin_2#1324#2838#1#ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.675	gnl|BL_ORD_ID|1398|hsp_num:0	776
BGC0000656.1|Zeaxanthin_3	ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.715	2834	3769	+	Loose	n/a	8.72043	iri	34.55	ARO:3002884	iri	protein homolog model	n/a	determinant of rifamycin resistance; antibiotic inactivation enzyme	antibiotic inactivation enzyme; determinant of rifamycin resistance	900	24.2534	24.2534	ATGAGCACGCCTGCGCCTACCGTCCTCGGTGCCAGCGAGGAGGCCATAAACAAGGGCTCCAAGAGCTTCGCCGCCGCCGCGCGCCTGTTCGGCCCGCGCATGCGGGAAGACGCGGTGATGCTCTATGCCTGGTGCCGCCACTGCGACGACGTGGTGGACGGGCAGGAACTGGGGCACGGGCGTGTCTCCAGCGCCGCCTCGCCCGCCGAGCGGCTCGATGGCCTCTATGAGGAGACCCGCAACGCCTATCGCGGCGCGCCCTCCGCCCATCCGGCCTTCGCCGCCTTCGCCGAGGTGGTGAAGCGCAACGACATTCCCGAGCGCTATCCCCTTCAACTGCTGGAGGGCTTCCGCATGGACGTGGAAGGCCGGCGCTACGACACCCTCGATGACACGCTCACCTATTGCTACCACGTGGCCGGCGTGGTGGGCGTGATGATGGCCCTCATCATGGGCGCGCGGGATGAAGTGGTGCTGGACCGGGCGAGCGACCTCGGCCTCGGCTTCCAGCTCACCAACATCGCCCGCGACGTGATGGAGGATGCCGCCATCGGCCGCATCTACCTGCCGGCGGCCTTCCTCGCAGAGGCCGGCGTGCCGGAGGCGGCCATCGCCGCGCCGGAGCACCGCGCGGCGGTGGCCGGCGTGGTGGCGCGGCTGCTCGACGTGGCCGAGCCCTATTACGACCAGGCCCTCATCGGCATGGCCGCCCTGCCGTTCCGCGCGGCGGCAGCGGTGGGCGCGGCGCGTGGGGTCTATCGCGCCATCGGCATCGAGGTCCGTAAGCGCGGGCCGAAGGCGTGGGATACCCGCGTCTCCACCTCCACGGCCCAGAAGGCCGGCTTTCTCGCGGGTGGCCTCGCGCAGGCCCTCGCCACGCGGTTCAGAGGCGCGCCGCCGCCCCGTCCCGCGCATCTTTGGACGCGTCCCGCATGA	MSTPAPTVLGASEEAINKGSKSFAAAARLFGPRMREDAVMLYAWCRHCDDVVDGQELGHGRVSSAASPAERLDGLYEETRNAYRGAPSAHPAFAAFAEVVKRNDIPERYPLQLLEGFRMDVEGRRYDTLDDTLTYCYHVAGVVGVMMALIMGARDEVVLDRASDLGLGFQLTNIARDVMEDAAIGRIYLPAAFLAEAGVPEAAIAAPEHRAAVAGVVARLLDVAEPYYDQALIGMAALPFRAAAAVGAARGVYRAIGIEVRKRGPKAWDTRVSTSTAQKAGFLAGGLAQALATRFRGAPPPRPAHLWTRPA	MSDVIIVGAGPTGLMLAGELRLQGVDVVVVDKDEEPTQFVRALGIHVRSIEIMEQRGLLDKFLAHGRKYPLGGFFAGISKPAPAHLDTAHGYVLGIPQPEIDRILAEHATEVGADIQRGKRVVAIRQDTDNVAAELSDGTTLHARYLVGCDGGRSTVRKLRSTSVFPASRTSADTLIGEMDVTMPADELAAVVAEIRETHKRFGVGPAGNGAFRVVVPAAEVADGRATPTTLDDIKQQLLAIAGTDFGVHSPRWLSRFGDATRLADDYRRDRVFLAGDAAHIHPPMGGQGLNLGVQDAFNLGWKLAAEINGWAPVGLLDTYESERRPVAADVLDNTRAQAELISTAAGPQAVRRLISELMEFEDVKRYLTEKITAISIRYDFGEGDDLLGRRLRNIALTRGNLYDLMRSGRGLLLDQGGQLSVDGWSDRADHIVDTSTELEAPAVLLRPDGHVAWIGDAQAELDTQLSTWFGRSARDRA	BGC0000656.1|Zeaxanthin_3#2835#3770#1#ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.715	gnl|BL_ORD_ID|753|hsp_num:0	796
